Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Journal of Controlled Release, 87(13), 187198
That Anti-LOX (30.50 0.65 mm), HCG (28.83 0.69 mm), VED (30.75 0.25 mm), Anti-LOX + VED (33.42 0.89 mm), HCG + VED (31.17 1.55 mm), and Anti-LOX + HCG + VED (33.25 0.80 mm) significantly increased exposed length ( p 0.05) but significantly shorter than Anti-LOX ( p 0.05)
M., Paxinos, G., Kenney, M
Metz TO, Qian WJ, Jacobs JM et al (2008) Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset
Biochemical Pharmacology 42: 645-654.CrossRefGoogle ScholarPubMed DASKIRAN, M
US$ 26.74
US$ 24.40
US$ 21.43
